BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, June 6, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 5, 2015
View Archived Issues
NINDS to study Thrombolytic Science's dual thrombolytic therapy for acute ischemic stroke
Read More
Astellas and Anokion form Kanyos to develop autoimmune disease therapies
Read More
NCCN and Pfizer establish grant program to improve patient care in metastatic breast cancer
Read More
Novo Nordisk introduces human PYY analogues
Read More
Business collaboration agreement signed betwwen JCR Pharma and Shin Nippon
Read More
Sigma-Aldrich to sell Xcell Science's neural cells as research tools
Read More
Protein disulfide isomerase inhibitors may be used to treat chikungunya virus infection
Read More
Sustained responses seen with LY-2951742 in migraineurs
Read More
Genmab licenses antibodies targeting CD19 from Bristol-Myers Squibb
Read More
Interim phase II pediatric data on KRN-23 for X-linked hypophosphatemia lead to trial expansion
Read More
Weill Cornell Medical College and Cellectis enter strategic translational research alliance in AML
Read More
ONO-2952, a TSPO antagonist for IBS-D: RESTORE-4 phase II clinical results
Read More
Pronutria to use KineMed's proteomics platform to evaluate biologics for amino acid homeostasis
Read More
Vectura initiates phase I trial of asthma candidate VR-942
Read More
FDA grants orphan drug designation to APTO-253 for AML
Read More
Stempeucel gets E.U. orphan drug designation
Read More
ABT-414 shows potential for the treatment of solid tumors
Read More
FDA clears IND for phase II trial of ADXS-HPV and epacadostat in cervical cancer
Read More
Emergent BioSolutions uses ProBioGen's duck cell line to produce clinical supplies of MVA-EBOZ
Read More
Bristol-Myers Squibb discloses CK1 inhibitors
Read More
KAEL-GemVax announces TNF-alpha production inhibitors
Read More
ViroCura patents HCV NS3/4A inhibitors
Read More
Sysmex and LabCorp form strategic collaboration to advance precision medicine for cancer
Read More
Midatech Pharma proposes to acquire DARA BioSciences
Read More
Regulus Therapeutics starts phase I trial of Alport syndrome candidate RG-012
Read More
Fast track designation for RE-024 in pantothenate kinase-associated neurodegeneration
Read More
FDA advisory committee recommends approval of Addyi for HSDD
Read More
Biogen files MAA for Alprolix for hemophilia B
Read More
